Leading source of Financial News, Investor Forums, CEO Interviews, Financial Columnists, Stock Information

Add to MyProactive

Open Orphan PLC - Open Orphan PLC's Cathal Friel details merger with 'sleeping giant' hVIVO

Open Orphan PLC's Cathal Friel details merger with 'sleeping giant' hVIVO

49 minutes ago

ReNeuron Group PLC - ReNeuron in active on-going talks for further potential out-licence deals

Full interview: ReNeuron in active on-going talks for further potential out-licence deals

2 hours, 41 minutes ago

DeepMatter Group PLC - DeepMatter inks collaboration with AstraZeneca PLC

DeepMatter inks AI collaboration with AstraZeneca

4 hours, 37 minutes ago

DeepMatter Group PLC - Investor Update: DeepMatter to collaborate with AstraZeneca

Investor Update: DeepMatter to collaborate with AstraZeneca

4 hours, 42 minutes ago

PureTech Health plc - PureTech Health plc’s affiliate Gelesis secures US$84.6mln to commercialise obesity drug US launch

PureTech affiliate Gelesis secures $85mln to launch obesity drug in US

5 hours, 27 minutes ago

Open Orphan PLC -

Open Orphan and hVIVO to merge

5 hours, 50 minutes ago

woman touching her skin

Integumen's digital revolution builds momentum

7 hours, 17 minutes ago

ImmuPharma PLC - ImmuPharma’s Lupuzor could be US blockbuster, says Life Sciences Division

ImmuPharma’s Lupuzor could be US blockbuster, says Life Sciences Division

2 days, 22 hours ago

Summit Therapeutics PLC -

Summit Therapeutics gets US$50mln backing from biotech billionaire Bob Duggan

3 days ago

ReNeuron Group PLC -

ReNeuron interims chart a period of significant progress; out-licence deal talks ongoing

3 days, 2 hours ago

ImmuPharma PLC -

ImmuPharma's US licensing deal provides a path to commercialisation for flagship lupus drug

3 days, 6 hours ago

dna strand

ReNeuron progresses as it gathers more data for developing treatments

3 days, 7 hours ago

Midatech Pharma PLC - Midatech Pharma jump as it receives €2.6mln EU grant to conduct clinical trial of MXT110 cancer treatment

Midatech Pharma jump as it receives €2.6mln EU grant to conduct clinical trial of MXT110 cancer treatment

3 days, 22 hours ago

MaxCyte Inc - MaxCyte offering exposure to 'explosive growth' in cell therapy and cellular engineering

MaxCyte offering exposure to 'explosive growth' in cell therapy and cellular engineering

4 days ago

Arecor -

Arecor boasts "favourable profile” for fast-acting insulin in phase I trial

4 days, 2 hours ago

AstraZeneca - AstraZeneca’s Lynparza approved in China as first ovarian cancer treatment of its kind

AstraZeneca’s presence in China boosted by Lynparza approval for ovarian cancer

4 days, 4 hours ago

Circassia Pharmaceuticals PLC -

Circassia completes managerial changes as Johnson becomes executive chairman

4 days, 4 hours ago

ImmuPharma PLC - ImmuPharma's Tim McCarthy details Lupuzor licensing deal with Avion Pharmaceuticals

ImmuPharma's Tim McCarthy details Lupuzor licensing deal with Avion Pharmaceuticals

4 days, 5 hours ago

Ipsen - Open Orphan 'continuing to target rapid scale-up and profitability'

Open Orphan 'continuing to target rapid scale-up and profitability'

4 days, 6 hours ago

VolitionRx - VolitionRx CEO discusses 'spectacular' results from Nu.Q proof of concept study

VolitionRx CEO discusses 'spectacular' results from Nu.Q proof of concept study

5 days, 1 hour ago

Follow us on:

© Proactive Investors 2019.

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority. Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use.